Categories AlphaGraphs, Earnings, Health Care
Vertex Pharmaceuticals (VRTX) reports Q1 2020 earnings results
Revised full-year product revenue guidance
Vertex Pharmaceuticals (Nasdaq: VRTX) today reported first quarter financial results for the period ended March 31, 2020.
On GAAP basis, first quarter EPS was $2.29 vs. $1.03 in the first quarter of 2019. Non-GAAP EPS was $2.56, compared to $1.14 in the first quarter of 2019.
Total revenues increased 76% to $1.51 billion.
You may also like:
Most Popular
Key highlights from Hewlett Packard Enterprise’s (HPE) Q1 2025 earnings results
Hewlett Packard Enterprise (NYSE: HPE) reported its first quarter 2025 earnings results today. Revenue was $7.9 billion, up 16% year-over-year and 17% in constant currency. Net earnings attributable to common
AVGO Infographic: Broadcom Q1 2025 revenue and earnings beat estimates
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) reported higher revenue and adjusted earnings for the first quarter of 2025. The numbers also surpassed Wall Street's expectations. Earnings, excluding special items, increased
Macy’s (M) Q4 2024 Earnings: Key financials and quarterly highlights
Macy’s Inc. (NYSE: M) reported its fourth quarter 2024 earnings results today. Net sales decreased 4.3% year-over-year to $7.8 billion. Comparable sales were down 1.1% on an owned basis and
